prodchem
Aug 21, 2026
Clariant is placing an increasingly strong bet on China as a source of future growth, making the country an important part of the Swiss specialty-chemical company's medium-term strategy. China currently represents around 10% of Clariant's global sales, with management targeting approximately 14% in the coming years.
That positioning stands out against a difficult European chemical environment, where high energy costs, weak industrial demand and competition from lower-cost producers continue to pressure manufacturers.
For investors, chemical suppliers and procurement teams, Clariant's strategy provides a useful case study in how European specialty-chemical companies are balancing domestic challenges with growth opportunities in China.
China is no longer simply a large destination market for chemical products.
It has become increasingly important for:
Manufacturing
Specialty chemicals
Electric vehicles
Pharmaceuticals
Personal care
Agrochemicals
Advanced materials
Clariant is positioning its portfolio around several of these growth areas.
The company has specifically identified opportunities linked to new energy vehicles, pharmaceuticals, personal and home care, industrial applications and agrochemicals.
Clariant has been expanding its production presence in China rather than relying solely on exports from Europe.
Its new facilities in Daya Bay include production capabilities for care chemicals and additives, supporting the company's strategy to grow closer to customers in the region.
This approach provides several advantages.
Local production can reduce:
Transport costs
Delivery times
Import exposure
Supply-chain complexity
It can also allow Clariant to develop products specifically for Asian customers.
The opportunity is significant, but China's chemical market is becoming increasingly competitive.
Domestic producers have expanded capacity across numerous chemical value chains, creating pressure on pricing and margins.
At the same time, China's economic recovery has shown signs of weakness. Industrial output grew 4.5% year-on-year in July 2026, while retail sales increased only 0.6%.
For specialty chemical companies, this creates a balancing act:
China offers growth potential, but also increasing competitive pressure.
Clariant's China strategy is not simply about increasing commodity chemical volumes.
Its portfolio is concentrated on specialty applications where technical performance and customer relationships can provide greater differentiation.
Key areas include:
Care chemicals
Additives
Catalysts
Mining solutions
Industrial applications
Agrochemicals
This matters because specialty chemicals can offer better opportunities for value-based pricing than highly commoditized products.
The strategic significance of China becomes clearer when viewed against Europe's chemical environment.
European producers continue to face:
Higher energy costs
Expensive feedstocks
Weak industrial demand
Global competition
Capacity rationalization
C&EN has described Europe's chemical sector as facing increasing pressure from cheaper imports and declining domestic production competitiveness.
For companies such as Clariant, expanding in faster-growing markets can therefore help offset slower European growth.
China expansion should not be interpreted as a complete shift away from Europe.
Clariant continues to operate a global production network and is using cost management and portfolio optimization to improve competitiveness.
In its latest results, the company increased its annual performance-improvement program to CHF 100 million, with CHF 90 million expected to be achieved during 2026.
This creates a two-part strategy:
Defend profitability in mature markets
Invest selectively in growth markets
Clariant's positioning also benefits from the nature of its business.
Specialty chemical customers often require:
Technical support
Consistent quality
Product qualification
Application expertise
Reliable supply
Regulatory documentation
These factors can make relationships more durable than in commodity markets.
For Clariant, this provides an opportunity to build long-term customer relationships in China's expanding industrial sectors.
China is the world's largest electric-vehicle market, creating demand for a wide range of chemical products.
Specialty chemicals can support:
Battery production
Coatings
Plastics
Lubricants
Adhesives
Manufacturing processes
Clariant has specifically identified the new-energy-vehicle sector as one of the downstream markets supporting its China growth strategy.
Clariant's China opportunity also extends beyond industrial manufacturing.
Personal and home care and pharmaceutical applications can provide exposure to consumer and healthcare-related demand.
This diversification is strategically useful because different end markets experience different economic cycles.
If industrial demand weakens, consumer or healthcare-related applications may provide some offset.
For buyers, the expansion of European specialty chemical companies in China can create additional sourcing options.
Procurement teams should monitor:
Local production capacity
New plant start-ups
Supplier localization
Product qualification
Regional pricing
Import requirements
Logistics costs
Alternative Asian suppliers
Greater local production can potentially improve supply reliability while reducing dependence on long-distance European shipments.
The Clariant strategy reflects a broader industry question.
Should European chemical companies continue investing heavily in their domestic manufacturing base?
Or should they redirect more capital toward markets where demand and industrial investment are growing?
There is no single answer.
The strongest strategy may increasingly involve:
European technology + Asian production + global customer networks.
Investors evaluating Clariant's China strategy should monitor:
Does China's share of group sales move toward the targeted 14%?
Are new Chinese facilities operating at attractive utilization rates?
Does China growth generate attractive profitability?
Is growth coming from diversified specialty applications?
Is Clariant continuing to prioritize China while maintaining financial discipline?
Procurement professionals should focus on whether expanded Chinese production translates into:
Shorter lead times
Greater supply availability
Competitive pricing
Local technical support
More sourcing flexibility
At the same time, buyers should evaluate geopolitical and regional concentration risks before increasing dependence on any single market.
Clariant's China strategy illustrates how European specialty chemical companies are adapting to a changing global industry.
Europe remains an important technology and customer base, but China is increasingly becoming a critical source of demand, production and investment.
Clariant's goal of increasing China's contribution from around 10% toward 14% of sales provides a measurable benchmark for this transition.
The broader question is whether other European specialty chemical companies will follow a similar path.
If China's specialty-chemical demand continues expanding, companies with localized production, strong application technology and established customer relationships could be better positioned to capture that growth.
For procurement teams, the trend could also create a more diversified supplier landscape—but one that requires careful evaluation of regional concentration and competitive risks.
China represents around 10% of Clariant's sales, with management targeting approximately 14%.
Clariant has expanded its Chinese production footprint, including new facilities in Daya Bay.
New-energy vehicles, pharmaceuticals, personal care and agrochemicals are important target markets.
China's growing specialty-chemical capacity creates both opportunities and competitive pressure.
European chemical producers face significant energy, cost and competitiveness challenges.
Clariant is combining China investment with cost reduction and portfolio optimization.
Its specialty-chemical positioning provides greater differentiation than commodity chemical exposure.
Procurement teams should track localized production, capacity, pricing and supplier concentration.
Clariant's China sales target provides a useful benchmark for comparing European specialty-chemical strategies.
The broader trend points toward increasingly regionalized chemical production and global customer networks.
Featured Product
Found this useful?
Continue Reading
BASF's Ludwigshafen restructuring is reducing capacity in parts of its bulk chemical footprint while keeping selected specialty product lines operating. For chemical buyers, the shift highlights why specialty materials can remain strategically important even as producers streamline major industrial sites.
Chennai's co-located Cosmetics, Homecare and Cospack expos are creating a broader meeting point for specialty ingredient suppliers, formulators and packaging professionals. The combined event circuit can open new sourcing and application opportunities across several end-use markets.
Semiconducting covalent organic frameworks are emerging as promising materials for battery research, combining porous structures with electronic functionality. Their potential could create new opportunities for energy storage material development and sourcing.
